(5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL 2-ETHOXY-1-((2'-(4-ETHYL-4,5-DIHYDRO-5-OXO-1,2,4-OXADIAZOL-3-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-1H-BENZIMIDAZOLE-7-CARBOXYLATE
UNII 5E59HE85EJ
Substance Identification & Data
This profile provides standardized clinical and technical data for (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(4-ethyl-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-benzimidazole-7-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5E59HE85EJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1417576-01-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H28N4O8 MKIYPVLTVAXBIW-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(4-ethyl-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-1h-benzimidazole-7-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.